| 1 |
Reizine F, Delbove A, dos Santos A, Bodenes L, Bouju P, Fillâtre P, et al. Clinical spectrum and risk factors for mortality among seawater and freshwater critically ill drowning patients: a French multicenter study. Crit Care. 2021; 25(1): 372.
doi: 10.1186/s13054-021-03792-2
|
| 2 |
Meddings DR, Scarr JP, Larson K, Vaughan J, Krug EG. Drowning prevention: turning the tide on a leading killer. Lancet Public Health. 2021 ;6(9): e692-e695.
|
| 3 |
Szpilman D, Morgan PJ. Management for the drowning patient. Chest. 2021; 159(4): 1473-83.
doi: 10.1016/j.chest.2020.10.007
|
| 4 |
Thiara AP, Høyland V, Norum H, Aasmundstad TA, Karlsen HM, Fiane AE, et al. Extracorporeal membrane oxygenation support for 59 days without changing the ECMO circuit: a case of Legionella pneumonia. Perfusion. 2009;24(1): 45-7.
|
| 5 |
Naqvi A, Kapoor S, Pradhan M, Dicpinigaitis PV. Outcomes of severe Legionella pneumonia requiring extracorporeal membrane oxygenation (ECMO). J Crit Care. 2021; 61: 103-6.
doi: 10.1016/j.jcrc.2020.10.017
pmid: 33157304
|
| 6 |
Dubois J, Dubois M, Martel JF. In vitro and intracellular activities of omadacycline against Legionella pneumophila. Antimicrob Agents Chemother. 2020; 64(5): e01972-19.
|
| 7 |
Markarian T, Loundou A, Heyer V, Marimoutou C, Borghese L, Coulange M, et al. Drowning classification: a reappraisal of clinical presentation and prognosis for severe cases. Chest. 2020; 158(2): 596-602.
doi: S0012-3692(20)30271-3
pmid: 32067943
|
| 8 |
Michelet P, Dusart M, Boiron L, Marmin J, Mokni T, Loundou A, et al. Drowning in fresh or salt water: respective influence on respiratory function in a matched cohort study. Eur J Emerg Med. 2019; 26(5): 340-4.
doi: 10.1097/MEJ.0000000000000564
pmid: 30080702
|
| 9 |
Cerland L, Mégarbane B, Kallel H, Brouste Y, Mehdaoui H, Resiere D. Incidence and consequences of near-drowning-related pneumonia-a descriptive series from Martinique, French West Indies. Int J Environ Res Public Health. 2017; 14(11):1402.
doi: 10.3390/ijerph14111402
|
| 10 |
Pierre DM, Baron J, Yu VL, Stout JE. Diagnostic testing for Legionnaires' disease. Ann Clin Microbiol Antimicrob. 2017; 16(1):59.
doi: 10.1186/s12941-017-0229-6
|
| 11 |
Torres A, Garrity-Ryan L, Kirsch C, Steenbergen JN, Eckburg PB, Das AF, et al. Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia. Int J Infect Dis. 2021; 104:501-9.
doi: 10.1016/j.ijid.2021.01.032
pmid: 33484864
|
| 12 |
Stets R, Popescu M, Gonong JR, Mitha I, Nseir W, Madej A, et al. Omadacycline for community-acquired bacterial pneumonia. N Engl J Med. 2019; 380(6): 517-27.
doi: 10.1056/NEJMoa1800201
|
| 13 |
Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging. 2010; 27:193-209.
doi: 10.2165/11531490-000000000-00000
pmid: 20210367
|
Open Access 
), Wenqi Qi, Haizhen Wang, Zhongjun Zheng, Libing Jiang, Shanxiang Xu
